Literature DB >> 31719671

Emerging intersections between neuroscience and glioma biology.

Erik Jung1,2, Julieta Alfonso3, Matthias Osswald1,2, Hannah Monyer3,4, Wolfgang Wick1,2, Frank Winkler5,6.   

Abstract

The establishment of neuronal and glial networks in the brain depends on the activities of neural progenitors, which are influenced by cell-intrinsic mechanisms, interactions with the local microenvironment and long-range signaling. Progress in neuroscience has helped identify key factors in CNS development. In parallel, studies in recent years have increased our understanding of molecular and cellular factors in the development and growth of primary brain tumors. To thrive, glioma cells exploit pathways that are active in normal CNS progenitor cells, as well as in normal neurotransmitter signaling. Furthermore, tumor cells of incurable gliomas integrate into communicating multicellular networks, where they are interconnected through neurite-like cellular protrusions. In this Review, we discuss evidence that CNS development, organization and function share a number of common features with glioma progression and malignancy. These include mechanisms used by cells to proliferate and migrate, interact with their microenvironment and integrate into multicellular networks. The emerging intersections between the fields of neuroscience and neuro-oncology considered in this review point to new research directions and novel therapeutic opportunities.

Entities:  

Mesh:

Year:  2019        PMID: 31719671     DOI: 10.1038/s41593-019-0540-y

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  147 in total

1.  Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration.

Authors:  Nader Sanai; Anthony D Tramontin; Alfredo Quiñones-Hinojosa; Nicholas M Barbaro; Nalin Gupta; Sandeep Kunwar; Michael T Lawton; Michael W McDermott; Andrew T Parsa; José Manuel-García Verdugo; Mitchel S Berger; Arturo Alvarez-Buylla
Journal:  Nature       Date:  2004-02-19       Impact factor: 49.962

Review 2.  Paediatric and adult malignant glioma: close relatives or distant cousins?

Authors:  Chris Jones; Lara Perryman; Darren Hargrave
Journal:  Nat Rev Clin Oncol       Date:  2012-05-29       Impact factor: 66.675

3.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.

Authors:  Quinn T Ostrom; Haley Gittleman; Jordan Xu; Courtney Kromer; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2016-10-01       Impact factor: 12.300

Review 4.  The Adult Ventricular-Subventricular Zone (V-SVZ) and Olfactory Bulb (OB) Neurogenesis.

Authors:  Daniel A Lim; Arturo Alvarez-Buylla
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-05-02       Impact factor: 10.005

Review 5.  Developmental origins and emerging therapeutic opportunities for childhood cancer.

Authors:  Mariella Filbin; Michelle Monje
Journal:  Nat Med       Date:  2019-03-06       Impact factor: 53.440

Review 6.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

Review 7.  Glioma.

Authors:  Michael Weller; Wolfgang Wick; Ken Aldape; Michael Brada; Mitchell Berger; Stefan M Pfister; Ryo Nishikawa; Mark Rosenthal; Patrick Y Wen; Roger Stupp; Guido Reifenberger
Journal:  Nat Rev Dis Primers       Date:  2015-07-16       Impact factor: 52.329

8.  Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England.

Authors:  Ramandeep S Arora; Robert D Alston; Tim O B Eden; Edward J Estlin; Anthony Moran; Jillian M Birch
Journal:  Neuro Oncol       Date:  2008-11-24       Impact factor: 12.300

Review 9.  A glial blueprint for gliomagenesis.

Authors:  Dylan Laug; Stacey M Glasgow; Benjamin Deneen
Journal:  Nat Rev Neurosci       Date:  2018-07       Impact factor: 34.870

10.  Corridors of migrating neurons in the human brain and their decline during infancy.

Authors:  Nader Sanai; Thuhien Nguyen; Rebecca A Ihrie; Zaman Mirzadeh; Hui-Hsin Tsai; Michael Wong; Nalin Gupta; Mitchel S Berger; Eric Huang; Jose-Manuel Garcia-Verdugo; David H Rowitch; Arturo Alvarez-Buylla
Journal:  Nature       Date:  2011-09-28       Impact factor: 49.962

View more
  31 in total

Review 1.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

Review 2.  Insights and opportunities at the crossroads of cancer and neuroscience.

Authors:  Chenchen Pan; Frank Winkler
Journal:  Nat Cell Biol       Date:  2022-09-12       Impact factor: 28.213

Review 3.  Dissecting cell fate dynamics in pediatric glioblastoma through the lens of complex systems and cellular cybernetics.

Authors:  Abicumaran Uthamacumaran
Journal:  Biol Cybern       Date:  2022-06-09       Impact factor: 3.072

4.  CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment.

Authors:  Fang Wang; Zhennan Tao; Zhen Tian; Jiaqi Jin; Jiawei Dong; Yuxiang Dai; Wanli Yu; Bin Tang; Shaoshan Hu
Journal:  Front Genet       Date:  2022-07-05       Impact factor: 4.772

Review 5.  The Network of Tumor Microtubes: An Improperly Reactivated Neural Cell Network With Stemness Feature for Resistance and Recurrence in Gliomas.

Authors:  Xinyue Wang; Jianhao Liang; Haitao Sun
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

6.  Prognostic Neurotransmitter Receptors Genes Are Associated with Immune Response, Inflammation and Cancer Hallmarks in Brain Tumors.

Authors:  Yuri Belotti; Serenella Tolomeo; Rongjun Yu; Wan-Teck Lim; Chwee Teck Lim
Journal:  Cancers (Basel)       Date:  2022-05-21       Impact factor: 6.575

7.  TRIM24 promotes stemness and invasiveness of glioblastoma cells via activating Sox2 expression.

Authors:  Lu-Hua Zhang; Yi-Heng Yin; Hong-Zun Chen; Shi-Yu Feng; Jia-Lin Liu; Ling Chen; Wen-Liang Fu; Guo-Chen Sun; Xin-Guang Yu; Dong-Gang Xu
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

Review 8.  In Vitro Glioblastoma Models: A Journey into the Third Dimension.

Authors:  Mayra Paolillo; Sergio Comincini; Sergio Schinelli
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

9.  Glioblastoma Proximity to the Lateral Ventricle Alters Neurogenic Cell Populations of the Subventricular Zone.

Authors:  Luisina B Ripari; Emily S Norton; Raquel Bodoque-Villar; Stephanie Jeanneret; Montserrat Lara-Velazquez; Anna Carrano; Natanael Zarco; Carla A Vazquez-Ramos; Alfredo Quiñones-Hinojosa; Carlos de la Rosa-Prieto; Hugo Guerrero-Cázares
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 5.738

10.  Metabolic profiles of human brain parenchyma and glioma for rapid tissue diagnosis by targeted desorption electrospray ionization mass spectrometry.

Authors:  Rong Chen; Hannah Marie Brown; R Graham Cooks
Journal:  Anal Bioanal Chem       Date:  2021-08-09       Impact factor: 4.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.